KRYSTAL BIOTECH INC (KRYS:NASDAQ)
$341.12 -25.73 (-7.0138%)
Analysed KRYSTAL BIOTECH INC (KRYS:NASDAQ) News Sources
3 Soaring Stocks That May Have More Upside Ahead
07-07-2026
fool.com
These Are 5 Of The Best Stocks To Buy Or Watch Now
10-07-2026
yahoo.com
Krystal Biotech Set to Join S&P MidCap 400; Tutor Perini and V2X to Join S&P SmallCap 600
20-07-2026
yahoo.com
Krystal Biotech to Report Second Quarter 2026 Financial Results on August 3, 2026
23-07-2026
yahoo.com
These 3 Healthcare Stocks Have Crushed the Market This Year. Here's Why There's More Upside Ahead
24-07-2026
fool.com
Krystal Biotech, Inc. (KRYS) Earnings Expected to Grow: Should You Buy?
27-07-2026
yahoo.com
Harmony Biosciences Holdings, Inc. (HRMY) Reports Next Week: Wall Street Expects Earnings Growth
28-07-2026
yahoo.com
Krystal Biotech (KRYS) Is Up 7.9% After S&P 400 Move And New KB801 Patent Filing Update
30-07-2026
yahoo.com
Krystal Biotech (KRYS) Could Be 40% Overvalued As KB801 News Tests Its Price
30-07-2026
yahoo.com
Stock Market Checklist Helps Uncover Winners In Hot Biotechs
31-07-2026
yahoo.com
What is the current price of KRYSTAL BIOTECH INC (KRYS:NASDAQ)?
The current price of KRYSTAL BIOTECH INC (KRYS:NASDAQ) is $341.12.
KRYSTAL BIOTECH INC (KRYS:NASDAQ) absolute price change since previous trading day?
The absolute price change of KRYSTAL BIOTECH INC (KRYS:NASDAQ) since the previous trading day is $-25.73.
KRYSTAL BIOTECH INC (KRYS:NASDAQ) percentage price change since previous trading day?
The percentage price change of KRYSTAL BIOTECH INC (KRYS:NASDAQ) since the previous trading day is -7.0138%.
What is the most recent average sentiment score for KRYSTAL BIOTECH INC (KRYS:NASDAQ)?
The most recent average sentiment score for KRYSTAL BIOTECH INC (KRYS:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for KRYSTAL BIOTECH INC (KRYS:NASDAQ)?
The most recent sentiment for KRYSTAL BIOTECH INC (KRYS:NASDAQ) is .
SEC-8K** Filing Available For KRYSTAL BIOTECH INC (KRYS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.